2007•PubMedRequires access

[Development of newer antidepressant].

Ken Inada

Open publisher page 0 citations

Abstract

The development of antidepressant started from 1950's and it is based on monoamine hypothesis. Antidepressants enhance monoamine, such as serotonin, nor adrenaline and dopamine neurotransmission by blockade of monoamine transporter or monoamine oxydase. The antidepressants under clinical trials enhance those monoamine in various combinations. The development of newer antidepressants is still on pre-clinical trials. Those candidates such as neurotrophic factors and neuropeptides may show antidepressant effect without monoamine hypothesis and those are expected to overcome the limitation of existing antidepressant.

About this research paper

What this paper is about

The development of antidepressant started from 1950's and it is based on monoamine hypothesis. Antidepressants enhance monoamine, such as serotonin, nor adrenaline and dopamine neurotransmission by blockade of monoamine transporter or monoamine oxydase. The antidepressants under clinical trials enhance those monoamine in various combinations. The development of newer antidepressants is still on pre-clinical trials. Those candidates such as neurotrophic factors and neuropeptides may show antidepressant effect without monoamine hypothesis and those are expected to overcome the limitation of existing antidepressant.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The development of antidepressant started from 1950's and it is based on monoamine hypothesis. Antidepressants enhance monoamine, such as serotonin, nor adrenaline and dopamine neurotransmission by blockade of monoamine transporter or monoamine oxydase. The antidepressants under clinical trials enhance those monoamine in various combinations. The development of newer antidepressants is still on pre-clinical trials. Those candidates such as neurotrophic factors and neuropeptides may show antidepressant effect without monoamine hypothesis and those are expected to overcome the limitation of existing antidepressant.

Key concepts: Monoamine neurotransmitter, Antidepressant, Dopamine, Serotonin, Pharmacology, Medicine, Psychiatry, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
[Development of newer antidepressant]. — Research Paper | ScholarLens